Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Taohong Siwu Decoction may help treat deep vein thrombosis by reducing inflammation.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Dutasteride is approved to help manage prostate enlargement.

These medications for BPH have known risks and may have new side effects.

The Potts-Guy model best predicts skin permeability for the tested drugs.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

The method accurately measures Finasteride and Tamsulosin in tablets without interference.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

CTP-543 is generally safe for treating alopecia areata.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Cepharanthine shows promise as a COVID-19 treatment.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

A new delivery system makes Curcumin more effective and safer against viruses.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Desolvation of finasteride depends on environment and technique.